London Daily

Focus on the big picture.
Thursday, Oct 30, 2025

Chinese researchers find third Sinovac dose boosts Delta immune response

Chinese researchers find third Sinovac dose boosts Delta immune response

A number of countries are considering boosters or authorising them for certain groups amid the battle against the Delta variant.

A third dose of the Covid-19 vaccine by Sinovac Biotech can boost a flagging immune response to the highly transmissible Delta variant, a team of Chinese researchers has found.

Study participants who received a three-dose regimen of the Sinovac shot showed a more than 2½ times higher neutralising ability against Delta four weeks after the last shot, compared with those who received two doses or had recovered from a naturally acquired Covid-19 infection, according to the small-scale study that has not been peer-reviewed.

The researchers – including scientists from the Chinese Academy of Sciences, Peking University and the vaccine maker – said their data also indicated a third dose would allow vaccine protection to last longer.


The findings “rationalise the use of three-dose immunisation regimens for inactivated vaccines”, they wrote in a paper released on the server medRvix on Sunday.

“Our results demonstrate that a third-dose booster of inactivated vaccine can elicit an expeditious, robust and long-lasting recall humoral [immune] response,” they wrote.

Chinese health officials late last month recommended booster shots for high-risk and vulnerable groups, but said further study was needed before extra jabs were considered for the general public. Five of the seven vaccines in use domestically use an inactivated platform, which relies on a dead version of the virus to stimulate immune response.

Sinovac’s Covid-19 vaccine is among products headlining the domestic roll-out, which has surpassed 2 billion doses. The two-dose vaccine is also widely used around the world.

Limited real-world data has been published on how well the vaccine defends against the Delta variant, which is expected to become dominant worldwide.

Several countries are offering third shots of other vaccines as a boost to Sinovac’s shots following concerns about breakthrough infections as Delta spreads.

But vaccine makers globally have reported diminished protection against the strain, especially against symptomatic disease. A number of countries are considering boosters, or authorising them for certain groups, as concerns loom about the longevity of vaccines and a reduced ability to counter the Delta variant.

The latest study of Sinovac, which relied on lab work not real-world evidence, indicated that four weeks after their final dose the neutralising antibody levels evoked against the Delta variant in people vaccinated with two shots of Sinovac’s vaccine were reduced about 3.7 times compared to that against the original strain.

The researchers also found that six months after vaccination, people who received two doses did not have detectable neutralising activity against the Beta, Gamma and Delta variants, but after the third dose they “exhibited a robust recall” immune response to neutralise variants.

They said their research showed neutralising antibody levels similar to those recorded soon after the second dose were maintained 180 days after the third-dose booster – suggesting the vaccine could last longer with an additional shot.

The study included 22 people who had recovered from Covid-19, six healthy participants and 38 volunteers who received either two or three doses of the vaccine.


The researchers did not discuss what level of protection the vaccine would have against the Delta variant in the real world or the effectiveness against Delta for those six months out from their full vaccination.

Neutralising antibodies are believed to be a key component of the body’s immune defence and an indicator of vaccine effectiveness, but levels typically decline over time.

Another laboratory-based study by a team of British and Indian researchers released on Tuesday found Delta was six times less sensitive to antibodies from individuals who had recovered from a previous infection compared with the earlier dominant strain of the virus.

The variant was also eight times less sensitive to antibodies produced by vaccination with either the Pfizer-BioNTech or AstraZeneca vaccines. The researchers said there was a need to explore “strategies to boost vaccine responses”.

Newsletter

Related Articles

0:00
0:00
Close
UK and Vietnam Sign Landmark Migration Deal to Fast-Track Returns of Irregular Arrivals
UK Drug-Pricing Overhaul Essential for Life-Sciences Ambition, Says GSK Chief
Princesses Beatrice and Eugenie Temporarily Leave the UK Amid Their Parents’ Royal Fallout
UK Weighs Early End to Oil and Gas Windfall Tax as Reeves Seeks Investment Commitments
UK Retail Inflation Slows as Shop Prices Fall for First Time Since Spring
Next Raises Full-Year Profit Guidance After Strong Third-Quarter Performance
Reform UK’s Lee Anderson Admits to 'Gaming' Benefits System While Advocating Crackdown
United States and South Korea Conclude Major Trade Accord Worth $350 Billion
Hurricane Melissa Strikes Cuba After Devastating Jamaica With Record Winds
Vice President Vance to Headline Turning Point USA Campus Event at Ole Miss
U.S. Targets Maritime Narco-Routes While Border Pressure to Mexico Remains Limited
Bill Gates at 70: “I Have a Real Fear of Artificial Intelligence – and Also Regret”
Elon Musk Unveils Grokipedia: An AI-Driven Alternative to Wikipedia
Saudi Arabia Unveils Vision for First-Ever "Sky Stadium" Suspended Over Desert Floor
Amazon Announces 14 000 Corporate Job Cuts as AI Investment Accelerates
UK Shop Prices Fall for First Time Since March, Food Leads the Decline
London Stock Exchange Group ADR (LNSTY) Earns Zacks Rank #1 Upgrade on Rising Earnings Outlook
Soap legend Tony Adams, long-time star of Crossroads, dies at 84
Rachel Reeves Signals Tax Increases Ahead of November Budget Amid £20-50 Billion Fiscal Gap
NatWest Past Gains of 314% Spotlight Opportunity — But Some Key Risks Remain
UK Launches ‘Golden Age’ of Nuclear with £38 Billion Sizewell C Approval
UK Announces £1.08 Billion Budget for Offshore Wind Auction to Boost 2030 Capacity
UK Seeks Steel Alliance with EU and US to Counter China’s Over-Capacity
UK Struggles to Balance China as Both Strategic Threat and Valued Trading Partner
Argentina’s Markets Surge as Milei’s Party Secures Major Win
British Journalist Sami Hamdi Detained by U.S. Authorities After Visa Revocation Amid Israel-Gaza Commentary
King Charles Unveils UK’s First LGBT+ Armed Forces Memorial at National Memorial Arboretum
At ninety-two and re-elected: Paul Biya secures eighth term in Cameroon amid unrest
Racist Incidents Against UK Nurses Surge by 55%
UK Chancellor Rachel Reeves Cites Shared Concerns With Trump Administration as Foundation for Early US-UK Trade Deal
Essentra plc: A Closer Look at a UK ‘Penny Stock’ Opportunity Amid Market Weakness
U.S. and China Near Deal to Avert Rare-Earth Export Controls Ahead of Trump-Xi Summit
Justin time: Justin Herbert Shields Madison Beer with Impressive Reflex at Lakers Game
Russia’s President Putin Declares Burevestnik Nuclear Cruise Missile Ready for Deployment
Giuffre’s Memoir Alleges Maxwell Claimed Sexual Act with Clooney
House Republicans Move to Strip NYC Mayoral Front-Runner Zohran Mamdani of U.S. Citizenship
Record-High Spoiled Ballots Signal Voter Discontent in Ireland’s 2025 Presidential Election
Philippines’ Taal Volcano Erupts Overnight with 2.4 km Ash Plume
Albania’s Virtual AI 'Minister' Diella Set to 'Birth' Eighty-Three Digital Assistants for MPs
Tesla Unveils Vision for Optimus V3 as ‘Biggest Product of All Time’, Including Surgical Capabilities
Francis Ford Coppola Auctions Luxury Watches After Self-Financed Film Flop
Convicted Sex Offender Mistakenly Freed by UK Prison Service Arrested in London
United States and China Begin Constructive Trade Negotiations Ahead of Trump–Xi Summit
U.S. Treasury Sanctions Colombia’s President Gustavo Petro over Drug-Trafficking Allegations
Miss USA Crowns Nebraska’s Audrey Eckert Amid Leadership Overhaul
‘I Am Not Done’: Kamala Harris Signals Possible 2028 White House Run
NBA Faces Integrity Crisis After Mass Arrests in Gambling Scandal
Swift Heist at the Louvre Sees Eight French Crown Jewels Stolen in Under Seven Minutes
U.S. Halts Trade Talks with Canada After Ontario Ad Using Reagan Voice Triggers Diplomatic Fallout
Microsoft AI CEO: ‘We’re making an AI that you can trust your kids to use’ — but can Microsoft rebuild its own trust before fixing the industry’s?
×